- Original article
- Open Access
The effect of L-thyroxine hormone therapy on hearing loss in hypothyroid patients
The Egyptian Journal of Otolaryngology volume 33, pages637–644(2017)
The aim of this work was to study whether or not the hearing loss encountered in some hypothyroid patients can be improved with L-thyroxine hormone therapy, as other symptoms of hypothyroidism.
The study design was a prospective cohort one.
Patients and methods
This study included 30 patients of either sex who were proved to be in a hypothyroid state with an additional symptom of hearing impairment. The study was carried out in Alexandria Main University Hospital and was conducted in a prospective manner. All selected patients were proved to be in a hypothyroid state in the Endocrinology Department. Moreover, their symptom of hearing impairment was confirmed by thorough audiological examination supplemented by pure-tone audiometry plus tympanometry that was carried out in the ENT Department and the associate Audiology Unit. L-thyroxine treatment for hypothyroidism was initiated in all cases for 6 months to maintain a state of euthyroidism. At the end of 6 months, a repeat audiogram and tympanometry were performed in all patients in order to evaluate the efficacy of the said treatment protocol on the hearing in these patients. Cases proved to have hearing impairment irrelevant to the hypothyroid condition were excluded. Informed consent was compulsory for recruitment in this study.
Post-treatment assessment revealed that variable improvement was achieved in 48% of ears, whereas 52% did not respond to the given treatment, with the impairment remaining nearly the same as it was before. Of the improved ears, in 15% of ears hearing levels were restored to normal hearing levels. Thereby, adherence to replacement therapy may reverse the hearing deficits in a few number of hypothyroid patients.
There is a definitive improvement in hearing with the use of L-thyroxine treatment of hypothyroid patients with hearing impairment.
Kemp WR. Deafness in myxoedema. Br Med J 1907; 1:375.
Morgan JM, McCaffrey T. Head and neck manifestations of endocrine disease In: Gleeson M, editor. Scott -Brown’s otorhinolaryngology, head and neck surgery. London: Hodder Arnold 2008. p. 400.
Parving A, Parving HH, Lyngsøe J. Hearing sensitivity in patients with myxoedema before and after treatment with L-thyroxine. Acta Otolaryngol 1983; 95:315–321.
Parving A, Ostri B, Bretlau P, et al. Audiological and temporal bone findings in myxoedema Ann Otol Rhinol Laryngol 1986; 95:278–283.
Brenner M, Hoistad DL, Hain TC. Prevalence of thyroid dysfunction in patients with Meniere’s disease Arch Otolaryngol Head Neck Surg 2004; 130:226–228.
Ben-Tovim R, Zohar Y, Laurian N, et al. Auditory brainstem response in experimentally induced hypothyroidism in albino rats Laryngoscope 1985; 95:982–986.
Vanasse M, Fisher C, Berthezene F, et al. Normal auditory evoked potentials in adult hypothyroidism Laryngoscope 1989; 99:302–306.
Sachdev Y, Hall R. Effusions into body cavities in hypothyroidism Lancet 1975; 1:564–565.
Van’t Hoff W, Sturat DW. Deafness in myxoedema QJM 1979; 48:361–367.
Rubinstein M, Perlstein TP, Hildesheimer M. Cochlear action potentials in experimentally induced hypothyroidism in guinea pigs Acta Otolaryngol 1975; 79(Suppl 331):1–10.
Howarth F, Lloyd HE. Perceptive deafness in hypothyroidism Br Med J 1956; 1:431–433.
Ritter FN The effects of hypothyroidism upon the ear, nose and throat. A clinical and experimental study. Laryngoscope 1967; 77:1427–1479.
Post JT. Hypothyroid deafness. A clinical study of sensorineural deafness associated with hypothyroidism. Laryngoscope 1964: 74:221–232.
DeVos JA. Deafness in hypothyroidism. J Laryngol Otol 1963; 77:390–414.
Arduç A, Isık S, Allusoglu S, et al. Does acquired hypothyroidism affect the hearing functions? Turk J Endocrinol Metab 2015; 19:124–129.
Malik V, Shukla GK, Bhatia N. Hearing profile in hypothyroidism. Indian J Otolaryngol Head Neck Surg 2002; 54:285–290.
Santos KT, Dias NH, Mazeto GM, et al. Audiologic evaluation in patients with acquired hypothyroidism. Braz J Otorhinolaryngol 2010; 76:478–484.
Geslin LL, Santos SD, Hassani Y, et al. Factors associated with hearing impairment in patients with congenital hypothyroidism treated since the neonatal period: anational population based study. J Clin Endocrinol Metab 2013: 98:3644–3652.
Thornton AR, Jarvis SJ. Auditory brainstem response findings in hypothyroid and hyperthyroid disease. Clin Neurophysiol 2008; 119:786–790.
Fang Q, Giordimaina AM, Dolan DF, et al. Genetic background of Prop1(df) mutants provides remarkable protection against hypothyroidism-induced hearing impairment. J Assoc Res Otolaryngol 2012; 13:173–184.
Anand VT, Mann SB, Dash RJ, et al. Auditory investigations in hypothyroidism. Acta Otolaryngol 1989; 108:83–87.
Dokianakis G, Ferekidis E, Pantazopoulos P. Hearing loss and hyperthyroidism. Arch Otorhinolaryngol 1978; 219:351–353.
Karakuş CF, Altuntaş EE, Kılıçlı F, et al. Is sensorineural hearing loss related with thyroid metabolism disorders Indian J Otol 2015; 21:138–143.
Di Lorenzo L, Foggia L, Panza N, et al. Auditory brainstem responses in thyroid diseases before and after therapy. Horm Res 1995; 43:200–205.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
Hussein, M.M., Asal, S.I., Salem, T.M. et al. The effect of L-thyroxine hormone therapy on hearing loss in hypothyroid patients. Egypt J Otolaryngol 33, 637–644 (2017). https://doi.org/10.4103/ejo.ejo_25_17
- hearing loss
- L-thyroxine treatment